Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From Genes to Virtual Brain: Defining the Pathogenic Mechanisms Promoting Alfa-synuclein Seeding and Spreading in Parkinson's Disease.

NCT07474779 is registered in ClinicalTrials.gov with University of Pavia as lead sponsor.

NCT NCT07474779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From Genes to Virtual Brain: Defining the Pathogenic Mechanisms Promoting Alfa-synuclein Seeding and Spreading in Parkinson's Disease.
Lead sponsor
University of Pavia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 11, 2026
Completion date
February 28, 2029
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gba1 parkinson disease, parkinson's disease (pd), rem sleep behavior disorder (irbd)